Natural Beauty Bio-Technology Limited (HKG:0157)
Hong Kong · Delayed Price · Currency is HKD 0.4650
+0.0100 (2.20%)
Aug 21, 2026, 3:59 PM HKT
HKG:0157 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 523.38 | 538.83 | 353.65 | 336.02 | 335.88 | 487.81 | |
Revenue Growth | 13.43% | 52.36% | 5.25% | 0.04% | -31.14% | 18.78% |
Cost of Revenue | 276.22 | 245.49 | 151.32 | 135.67 | 146.75 | 181.81 |
Gross Profit | 247.16 | 293.34 | 202.33 | 200.35 | 189.13 | 306 |
Selling, General & Admin | 295.68 | 272.15 | 251.39 | 208.17 | 207.82 | 265.23 |
Other Operating Expenses | -13.04 | -7.39 | 0.4 | -4.17 | -4.09 | -1.38 |
Operating Expenses | 287.18 | 265.98 | 251.66 | 199.93 | 208.45 | 259.87 |
Operating Income | -40.02 | 27.36 | -49.33 | 0.42 | -19.32 | 46.13 |
Interest Expense | -12.44 | -10.47 | -8.05 | -8.13 | -4.34 | -1.82 |
Interest & Investment Income | 2.28 | 1.98 | 0.85 | 1.51 | 1.65 | 2.05 |
Earnings From Equity Investments | -1.53 | -0.9 | - | - | - | - |
Currency Exchange Gain (Loss) | 3.5 | - | - | - | 2.43 | - |
EBT Excluding Unusual Items | -48.2 | 17.98 | -56.53 | -6.21 | -19.58 | 46.36 |
Impairment of Goodwill | - | - | -24.81 | - | -2.13 | - |
Gain (Loss) on Sale of Assets | -0.08 | 0.19 | 0.01 | 0.1 | - | -0.2 |
Asset Writedown | -6.36 | -6.36 | -23.88 | -5.76 | -3.8 | 0.53 |
Other Unusual Items | - | - | - | - | 1.97 | 1.77 |
Pretax Income | -54.63 | 11.82 | -105.21 | -11.87 | -23.55 | 48.46 |
Income Tax Expense | 2.83 | 1.24 | -1.59 | 3.24 | 6.92 | 13.2 |
Net Income | -57.48 | 10.58 | -103.62 | -15.11 | -30.47 | 35.26 |
Net Income to Common | -57.48 | 10.58 | -103.62 | -15.11 | -30.47 | 35.26 |
Net Income Growth | - | - | - | - | - | 354.55% |
Shares Outstanding (Basic) | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 |
Shares Outstanding (Diluted) | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -0.03 | 0.01 | -0.05 | -0.01 | -0.02 | 0.02 |
EPS (Diluted) | -0.03 | 0.01 | -0.05 | -0.01 | -0.02 | 0.02 |
EPS Growth | - | - | - | - | - | 354.65% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -124.62 | -83.76 | -54.96 | -47.39 | -32.75 | 6.5 |
Free Cash Flow Per Share | -0.06 | -0.04 | -0.03 | -0.02 | -0.02 | 0.00 |
Dividend Per Share | - | - | - | - | - | 0.003 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | 47.22% | 54.44% | 57.21% | 59.62% | 56.31% | 62.73% |
Operating Margin | -7.65% | 5.08% | -13.95% | 0.12% | -5.75% | 9.46% |
Profit Margin | -10.98% | 1.96% | -29.30% | -4.50% | -9.07% | 7.23% |
Free Cash Flow Margin | -23.81% | -15.54% | -15.54% | -14.10% | -9.75% | 1.33% |
EBITDA | 0.44 | 57.78 | -23.02 | 21.4 | 4.61 | 72.04 |
EBITDA Margin | 0.08% | 10.72% | -6.51% | 6.37% | 1.37% | 14.77% |
D&A For EBITDA | 40.45 | 30.42 | 26.31 | 20.98 | 23.94 | 25.91 |
EBIT | -40.02 | 27.36 | -49.33 | 0.42 | -19.32 | 46.13 |
EBIT Margin | -7.65% | 5.08% | -13.95% | 0.12% | -5.75% | 9.46% |
Effective Tax Rate | - | 10.45% | - | - | - | 27.23% |
Advertising Expenses | - | 22.58 | 32.53 | 39.22 | 13.29 | 45.13 |